Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists.
Heeschen
C
C
Department of Cardiovascular Medicine, Stanford University School of Medicine, CA 94305, USA.
Hamm
C W
CW
D000284:Administration, Oral; D001241:Aspirin / Q000008:administration & dosage; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D010091:Oximes / Q000008:administration & dosage; D010880:Piperidines / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D012307:Risk Factors
D010091:Oximes; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D001241:Aspirin; C100917:sibrafiban